Tactile Systems Technology, Inc. (TCMD)

Price$23.98

Value ScoreB

Growth ScoreB

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-13.09%

Price vs S&P 500 (4W)2.54%

VGM Score69.02

Market Capitalization$540.45M

P/E Ratio (Annual)28.32x

All Metrics

P/CF (Annual)12.62x

Book Value / Share (Quarterly)$9.59

P/TBV (Annual)3.60x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)10.11%

Cash Flow / Share (Quarterly)$1.72

Price vs S&P 500 (YTD)-26.07%

Gross Margin (TTM)51.34%

Net Profit Margin (TTM)5.91%

EPS (TTM)$0.88

10-Day Avg Trading Volume0.28M

EPS Excl Extra (TTM)$0.88

Revenue Growth (5Y)11.99%

EPS (Annual)$0.82

ROI (Annual)8.72%

Gross Margin (Annual)50.79%

Net Profit Margin (5Y Avg)1.81%

Cash / Share (Quarterly)$3.97

P/E Basic Excl Extra (TTM)26.63x

Revenue Growth QoQ (YoY)22.85%

P/E Normalized (Annual)28.32x

ROA (Last FY)6.97%

Revenue Growth TTM (YoY)17.18%

EBITD / Share (TTM)$1.52

ROE (5Y Avg)1.47%

Operating Margin (TTM)9.40%

Cash Flow / Share (Annual)$1.79

P/B Ratio2.48x

P/B Ratio (Quarterly)2.73x

Net Income / Employee (Annual)$17,600

EV / Revenue (TTM)1.35x

ROA (TTM)7.53%

EPS Growth QoQ (YoY)14.51%

EV / EBITDA (TTM)13.42x

EPS Incl Extra (Annual)$0.82

Current Ratio (Annual)4.03x

Quick Ratio (Quarterly)3.57x

3-Month Avg Trading Volume0.33M

52-Week Price Return148.59%

EV / Free Cash Flow (Annual)11.56x

P/E Incl Extra (TTM)26.63x

Revenue / Employee (TTM)$316,300

Tangible BV / Share (Quarterly)$7.73

P/S Ratio (Annual)1.64x

Asset Turnover (Annual)1.20x

52-Week High$37.77

Operating Margin (5Y Avg)3.40%

EPS Excl Extra (Annual)$0.82

CapEx CAGR (5Y)2.05%

Tangible BV CAGR (5Y)7.86%

26-Week Price Return2.84%

Quick Ratio (Annual)3.49x

13-Week Price Return-17.72%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)4.24x

Enterprise Value$465.45M

Revenue / Share Growth (5Y)7.85%

Asset Turnover (TTM)1.27x

Book Value / Share Growth (5Y)8.80%

Revenue / Employee (Annual)$303,400

Inventory Turnover (Annual)9.92x

Pretax Margin (Annual)9.51%

Cash / Share (Annual)$4.42

3-Month Return Std Dev39.94%

Gross Margin (5Y Avg)49.45%

Net Income / Employee (TTM)$18,700

EBITDA CAGR (5Y)141.02%

EBITDA Interim CAGR (5Y)16.91%

ROE (Last FY)8.72%

EPS Basic Excl Extra (Annual)$0.82

P/FCF (TTM)13.42x

Receivables Turnover (TTM)9.30x

EV / Free Cash Flow (TTM)11.91x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$0.88

Receivables Turnover (Annual)7.42x

ROI (TTM)9.43%

P/S Ratio (TTM)1.57x

Pretax Margin (5Y Avg)3.18%

Revenue / Share (Annual)$14.15

Tangible BV / Share (Annual)$8.01

Forward P/E19.26x

Free OCF CAGR (5Y)140.56%

Price vs S&P 500 (52W)120.38%

P/E Ratio (TTM)26.63x

EPS Growth TTM (YoY)32.72%

Year-to-Date Return-15.14%

5-Day Price Return-1.16%

EPS Normalized (Annual)$0.82

ROA (5Y Avg)2.19%

Net Profit Margin (Annual)5.79%

Month-to-Date Return6.91%

Cash Flow / Share (TTM)$1.42

EBITD / Share (Annual)$1.36

Operating Margin (Annual)8.89%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)12.85x

ROI (5Y Avg)2.31%

P/E Excl Extra (TTM)26.63x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$0.88

P/TBV (Quarterly)3.39x

P/B Ratio (Annual)2.96x

Inventory Turnover (TTM)9.43x

Pretax Margin (TTM)10.05%

Book Value / Share (Annual)$9.76

Price vs S&P 500 (13W)-27.47%

Beta0.83x

P/FCF (Annual)13.42x

Revenue / Share (TTM)$15.23

ROE (TTM)9.70%

52-Week Low$9.41

vGradeB

gGradeB

mGradeC

vgmGradeB

Show chart for

Earnings Surprise History

Q1 26-0.08est. -0.10

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.18

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
TCMDTactile Systems Technology, Inc.	B	B	C	$23.98
SYKStryker Corporation	C	C	D	$299.46
MMM3M Company	C	F	C	$150.93
BSXBoston Scientific Corp.	C	B	F	$47.98
MDLNMedline Inc. Class A common stock	C	D	D	$35.75
BDXBecton, Dickinson and Co.	B	C	C	$145.33
DXCMDexCom, Inc.	C	B	C	$74.87
RMDResMed Inc.	B	B	D	$186.44
WSTWest Pharmaceutical Services, Inc.	D	C	B	$316.30
SOLVSolventum Corporation	C	D	C	$75.84
PENPenumbra, Inc.	F	C	C	$318.95

About

Tactile Systems Technology develops home-based medical devices for chronic disease management. The company's proprietary platforms include FlexiTouch for lymphedema treatment and AcuTouch for chronic venous insufficiency, along with additional solutions for chronic swelling. These wearable and home-based therapies enable patients to manage their conditions outside clinical settings.